Mucosal Vaccine Development Based on Liposome Technology

Immune protection against infectious diseases is most effective if located at the portal of entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that can induce strong protective immunity following oral, respiratory, or genital tract administration. At present, only f...

Full description

Bibliographic Details
Published in:	Journal of Immunology Research
Main Authors:	Valentina Bernasconi, Karin Norling, Marta Bally, Fredrik Höök, Nils Y. Lycke
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Online Access:	http://dx.doi.org/10.1155/2016/5482087

Similar Items

Nanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery
by: Leah M. Johnson, et al.
Published: (2019-08-01)

Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes.
by: Liulin Chen, et al.
Published: (2013-01-01)

The development of liposomal medicine technology in a form of solution for injection
by: G. I. Borshchevskіy
Published: (2015-12-01)

Development of pilot technology for liposomal irinotecan production
by: O. V. Stadnichenko, et al.
Published: (2018-08-01)

Mucosal vaccination: onward and upward
by: Catherine J. Y. Tsai, et al.
Published: (2023-12-01)

Liposome and polymer-based nanomaterials for vaccine applications
by: Piyachat Evelyn Roopngam
Published: (2019-01-01)

Research progress in the development of natural-product-based mucosal vaccine adjuvants
by: Yingying Gao, et al.
Published: (2023-04-01)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
by: Victoria Ozberk, et al.
Published: (2023-09-01)

Considerations for Novel COVID-19 Mucosal Vaccine Development
by: Wael Alturaiki
Published: (2022-07-01)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
by: Sahar Tahaghoghi-Hajghorbani, et al.
Published: (2023-04-01)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
by: William Wheat, et al.
Published: (2019-09-01)

Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting.
by: Grishma N Pawar, et al.
Published: (2018-01-01)

Vaccine approaches for antigen capture by liposomes
by: Shiqi Zhou, et al.
Published: (2023-12-01)

Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo
by: Wieslawa H. Dragowska, et al.
Published: (2024-12-01)

PERSPECTIVES OF THE DEVELOPMENT OF MUCOSAL VACCINES AGAINST DANGEROUS INFECTIONS ON THE BASE OF TRANSGENIC PLANTS
by: A.V. Tretyakova, et al.
Published: (2012-08-01)

Liposomes and mRNA: Two technologies together create a COVID-19 vaccine
by: Gregory Gregoriadis
Published: (2021-12-01)

Editorial: Vaccines on mucosal immunity
by: Alexander Suvorov, et al.
Published: (2025-07-01)

Liposomal delivery system/adjuvant for tuberculosis vaccine
by: Melika Moradi, et al.
Published: (2023-06-01)

Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes
by: Christina Monerat Toledo-Machado, et al.
Published: (2015-02-01)

Navigating Fish Immunity: Focus on Mucosal Immunity and the Evolving Landscape of Mucosal Vaccines
by: Mai G. Hopo, et al.
Published: (2024-11-01)

Systemic and Mucosal B and T Cell Responses Upon Mucosal Vaccination of Teleost Fish
by: Estefanía Muñoz-Atienza, et al.
Published: (2021-02-01)

Editorial: Mucosal immunity after vaccination
by: Mohd Arish, et al.
Published: (2025-09-01)

Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01)

Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers
by: Wenzhi Tan, et al.
Published: (2024-06-01)

Essential Role of Host Double-Stranded DNA Released from Dying Cells by Cationic Liposomes for Mucosal Adjuvanticity
by: Rui Tada, et al.
Published: (2019-12-01)

Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy
by: Jessica Kalra, et al.
Published: (2024-07-01)

Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3
by: Kyosuke eSenchi, et al.
Published: (2013-11-01)

Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines
by: Aloysious Ssemaganda, et al.
Published: (2019-02-01)

Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
by: Luis O. De Serrano, et al.
Published: (2017-11-01)

Development of a spore-based mucosal vaccine against the bovine respiratory pathogen Mannheimia haemolytica
by: Muhammed Salah Uddin, et al.
Published: (2023-08-01)

Development of mucosal vaccine via respiratory tract based on mRNA-peptide-poloxamine nanoparticles
by: YANG Qihua, et al.
Published: (2023-07-01)

The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines
by: Jieru Yang, et al.
Published: (2023-01-01)

Mimicking Pathogens to Augment the Potency of Liposomal Cancer Vaccines
by: Maarten K. Nijen Twilhaar, et al.
Published: (2021-06-01)

Liposomal Dendritic Cell Vaccine in Breast Cancer Immunotherapy
by: Hong Pan, et al.
Published: (2021-01-01)

Licensed liposomal vaccines and adjuvants in the antigen delivery system
by: Yuriy Krasnopolsky, et al.
Published: (2022-12-01)

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance
by: Noémi Anna Nagy, et al.
Published: (2021-05-01)

Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
by: Sodiq A. Hameed, et al.
Published: (2022-06-01)

Targeted prevention of radiation-induced oral mucositis by glutathione-modified liposome coated K12 probiotics and clinical study
by: ZhiHui Li, et al.
Published: (2025-10-01)

Analysis of risk factors in breast cancer patients with hand-foot syndrome and oral mucositis caused by pegylated liposomal doxorubicin
by: Xianghua Quan, et al.
Published: (2025-05-01)

Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol
by: Faheel Naeem, et al.
Published: (2021-06-01)